Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
Zevra Therapeutics
Market Cap: US$534.4m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$9.77
7D
27.4%
1Y
41.2%
Illumina
Market Cap: US$14.2b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$91.69
7D
-10.8%
1Y
-29.5%
DIOD Maker of Eco-Friendly Equipment and Nutrition
Market Cap: ₽677.1m
DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company researches, develops, manufactures, and sells nutritional supplements, pharmaceuticals, active cosmetics, and health equipment for home use.
DIOD
₽7.40
7D
0%
1Y
-13.5%
Respiratorius
Market Cap: SEK 39.4m
A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.
RESP
SEK 7.72
7D
-12.5%
1Y
n/a
Zhejiang Wolwo Bio-Pharmaceutical
Market Cap: CN¥14.7b
A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.
300357
CN¥28.05
7D
-2.4%
1Y
36.6%
RaQualia Pharma
Market Cap: JP¥14.2b
Engages in the research and development of pharmaceutical compounds worldwide.
4579
JP¥580.00
7D
-1.5%
1Y
4.5%
Beijing Strong BiotechnologiesInc
Market Cap: CN¥7.8b
Provides in-vitro diagnostics products and services in the People’s Republic of China and internationally.
300406
CN¥13.38
7D
-0.9%
1Y
0.6%
AstraZeneca Pharma India
Market Cap: ₹220.5b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹8,819.10
7D
-1.3%
1Y
22.7%
Shree Ganesh Remedies
Market Cap: ₹6.7b
Engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally.
540737
₹520.75
7D
-5.1%
1Y
-36.7%
WITHUS PHARMACEUTICALLTD
Market Cap: ₩91.9b
Engages in the production and sale of pharmaceutical products in South Korea.
A330350
₩6,960.00
7D
-3.2%
1Y
-3.3%
Innova Captab
Market Cap: ₹48.4b
An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.
INNOVACAP
₹845.05
7D
-1.9%
1Y
9.4%
Pacific Edge
Market Cap: NZ$190.1m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.19
7D
4.5%
1Y
24.0%
Biofil Chemicals and Pharmaceuticals
Market Cap: ₹679.8m
Engages in manufacturing and trading of pharmaceuticals in India.
524396
₹41.77
7D
-3.6%
1Y
-48.3%
ViGenCell
Market Cap: ₩80.0b
Specializes in immune cell therapy.
A308080
₩3,910.00
7D
0%
1Y
4.4%
Seegene
Market Cap: ₩1.2t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩25,000.00
7D
-6.0%
1Y
-2.9%
APTOCROM
Market Cap: ₩72.2b
Distributes pharmaceutical products in South Korea.
A109960
₩327.00
7D
-9.4%
1Y
-38.9%
Aarti Drugs
Market Cap: ₹42.9b
Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.
524348
₹470.00
7D
-10.5%
1Y
-8.6%
Lyka Labs
Market Cap: ₹3.4b
A pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India.
LYKALABS
₹94.85
7D
-5.6%
1Y
-35.5%
Influx Healthtech
Market Cap: ₹4.1b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹175.00
7D
-8.9%
1Y
n/a
Jubilant Pharmova
Market Cap: ₹165.4b
Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
530019
₹1,044.20
7D
-5.4%
1Y
-10.6%
Hunan Nucien Pharmaceutical
Market Cap: CN¥3.1b
A pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China.
688189
CN¥11.23
7D
-8.3%
1Y
75.7%
Sanai Health Industry Group
Market Cap: HK$67.3m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.44
7D
2.3%
1Y
116.7%
PharmaResearch
Market Cap: ₩6.0t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩578,000.00
7D
-3.2%
1Y
200.3%
Innovent Biologics
Market Cap: HK$159.7b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$93.25
7D
1.3%
1Y
100.1%
Jeil Pharma Holdings
Market Cap: ₩133.4b
Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.
A002620
₩8,690.00
7D
0.2%
1Y
-2.7%
Medtide
Market Cap: HK$4.3b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$30.60
7D
0%
1Y
n/a
GENINUS
Market Cap: ₩67.9b
A bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea.
A389030
₩2,035.00
7D
-1.2%
1Y
29.3%
D. Western Therapeutics Institute
Market Cap: JP¥6.7b
A biotechnology company, focuses on discovery and development of various drugs.
4576
JP¥146.00
7D
36.4%
1Y
92.1%
Orchid Pharma
Market Cap: ₹36.6b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹721.45
7D
-8.5%
1Y
-49.4%
Hyphens Pharma International
Market Cap: S$109.6m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.35
7D
-5.3%
1Y
22.4%
Shandong Buchang Pharmaceuticals
Market Cap: CN¥19.3b
Shandong Buchang Pharmaceuticals Co., Ltd.
603858
CN¥18.26
7D
-2.2%
1Y
8.2%
Livzon Pharmaceutical Group
Market Cap: CN¥31.8b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.
000513
CN¥38.23
7D
-2.6%
1Y
-0.5%
Beta Drugs
Market Cap: ₹18.3b
Develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India.
BETA
₹1,812.00
7D
-1.4%
1Y
13.5%
Guangdong Hybribio BiotechLtd
Market Cap: CN¥3.5b
Engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes.
300639
CN¥5.62
7D
-1.7%
1Y
-4.3%
ISU Abxis
Market Cap: ₩206.7b
A biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide.
A086890
₩5,230.00
7D
-5.1%
1Y
-17.2%
Jiangsu Jibeier Pharmaceutical
Market Cap: CN¥7.1b
A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.
688566
CN¥35.40
7D
-1.8%
1Y
60.9%